Pharmacokinetics and biotransformation of benzbromarone in man
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 19 (6) , 431-435
- https://doi.org/10.1007/bf00548587
Abstract
After administration of a single oral dose of benzbromarone 100 mg to 7 subjects, the maximum serum level was 1.84±0.87 mg/l, and the elimination halflife was 2.77±1.07 h. The major metabolite, benzarone, could be detected in serum 3 h after administration of benzbromarone, and the maximum serum benzarone level of 0.79±0.21 mg/l occurred after 6 h. Benzarone had an elimination half-life from serum of 13.52±2.18 h. Both substances were excreted mainly via the liver and bile. In urine only benzarone β-glucuronide could be detected; it amounted to 1.55% of the benzbromarone dose.Keywords
This publication has 9 references indexed in Scilit:
- High-performance liquid chromatographic determination of benzbromarone and the main metabolite benzarone in serumJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- BenzbromaroneDrugs, 1977
- Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.1976
- Distal permeability to urate and effects of benzofuran derivatives in the rat kidneyAmerican Journal of Physiology-Legacy Content, 1975
- Effect of single oral doses of benzbromarone on serum and urinary uric acidArthritis & Rheumatism, 1974
- Metabolism of benzbromarone in manEuropean Journal of Clinical Pharmacology, 1972
- Über die Wirkung von Benzbromaron auf den Serumharnsäurespiegel und die Harnsäureausscheidung des GichtkrankenDeutsche Medizinische Wochenschrift (1946), 1970
- [Treatment of hyperuricemic and gouty patients with derivatives of benzofuran].1967
- RECHERCHES DANS LA SERIE DES BENZOFURANNES .13. TRANSIT DE LETHYL-2 (HYDROXY-4' BENZOYL)-3 BENZOFURANNE CHEZ LHOMME ET CHEZ LANIMAL1965